Home
    Disclaimer
    ๐Ÿงช This is a research chemical with limited data on its long-term health effects, toxicity profile, and safe dosage ranges.

    AEM

    Aliases: ฮ‘-ethylmescaline, ฮ‘-ethyl-3,4,5-trimethoxyphenethylamine

    Summary TheDrug.Wiki

    AEM is an extremely rare and poorly documented phenethylamine psychedelic first synthesized by Alexander Shulgin and described in PiHKAL as entry #1. Shulgin reported that doses exceeding 220 mg produced few to no psychoactive effects, classifying it as essentially inactive. The compound's inactivity discouraged Shulgin from synthesizing further alpha-position-extended mescaline analogues (such as alpha-propylmescaline or alpha-butylmescaline).

    Dose Information TheDrug.Wiki

    ROA Light Common Strong Heavy
    Oral Unknown(inactive)mg - - -
    Light Common Strong Heavy

    Effect Profile

    Scores (1–10) curated from multiple sources:

    • Effect keyword matching from PsychonautWiki catalog
    • Weighted by importance: core (×3), major (×2), minor (×1)

    Full methodology

    Psychedelic 3.1
    Light+ 3/10

    Low visuals and headspace

    Visual Intensity ×3
    3
    color enhancement visual distortions
    Headspace Depth ×3
    2
    introspection
    Auditory Effects ×1
    0
    Body Load / Somatic Effects ×1
    0

    Tolerance

    Build-up develops within days of regular use; analgesic tolerance faster than respiratory depression tolerance
    Reset 7โ€“14 days for partial reset; full reset may take weeks โ€” tolerance loss greatly increases overdose risk

    Effects TheDrug.Wiki

    Neutral
    • Dilated pupils
    Positive
    • Introspection
    Neutral
    • No significant psychoactive effects reported
    Positive
    • Color enhancement
    Neutral
    • Visual distortions

    Combinations TripSit

    PiHKAL / TiHKAL Shulgin

    PiHKAL #1: AEM

    Helpful Links